Skip to main content

Crescendo Receives CAP Accreditation for CLIA Lab

Premium

Crescendo Bioscience said this week that it has received accreditation for its laboratory from the Commission on Laboratory Accreditation of the College of American Pathologists.

The accreditation offers further validation of the company's CLIA lab facility and its 12 protein Vectra DA test that it runs out of that facility, William Hagstrom, Crescendo's president and CEO said in a statement.

CAP accreditation involves examination of a laboratory’s records and quality control procedures for the preceding two years as well as examination of staff qualifications, laboratory equipment, safety programs and records, and overall laboratory management.

The U.S. government recognizes the CAP Laboratory Accreditation Program as being equal-to or more-stringent-than the government’s own inspection program, Crescendo said.

The CAP accreditation follows Crescendo's receipt in April of approval for its CLIA lab from the New York Department of Health's Clinical Laboratory Evaluation Program. With that approval, Vectra DA is now available in all 50 states.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.